Given the correlation between activation of cGAS/STING signaling and type I interferon innate immune responses, we next sought to assess the effects of Olaparib in combination with CDC7 inhibition on anti‐tumor immunity in vitro. The gene discussed is STING1; the disease is neoplasm.